227 related articles for article (PubMed ID: 28478450)
21. Dacomitinib, a new pan-EGFR inhibitor, is effective in attenuating pulmonary vascular remodeling and pulmonary hypertension.
Yu X; Zhao X; Zhang J; Li Y; Sheng P; Ma C; Zhang L; Hao X; Zheng X; Xing Y; Qiao H; Qu L; Zhu D
Eur J Pharmacol; 2019 May; 850():97-108. PubMed ID: 30753867
[TBL] [Abstract][Full Text] [Related]
22. PDGF-BB regulates splitting angiogenesis in skeletal muscle by limiting VEGF-induced endothelial proliferation.
Gianni-Barrera R; Butschkau A; Uccelli A; Certelli A; Valente P; Bartolomeo M; Groppa E; Burger MG; Hlushchuk R; Heberer M; Schaefer DJ; Gürke L; Djonov V; Vollmar B; Banfi A
Angiogenesis; 2018 Nov; 21(4):883-900. PubMed ID: 30014172
[TBL] [Abstract][Full Text] [Related]
23. [Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism].
Guo X; Li MX; Bayer C; Yang YQ; Wang L
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Apr; 25(4):407-414. PubMed ID: 37073847
[TBL] [Abstract][Full Text] [Related]
24. The Long Noncoding RNA LnRPT Is Regulated by PDGF-BB and Modulates the Proliferation of Pulmonary Artery Smooth Muscle Cells.
Chen J; Guo J; Cui X; Dai Y; Tang Z; Qu J; Raj JU; Hu Q; Gou D
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):181-193. PubMed ID: 28915060
[TBL] [Abstract][Full Text] [Related]
25. Sunitinib mesylate inhibits proliferation of human colonic stromal fibroblasts in vitro and in vivo.
Wang ZH; Li Q; Ruan SQ; Xiao Q; Liu Y; Hu YT; Hu LF; Chen HY; Zheng S; Zhang SZ; Ding KF
J Zhejiang Univ Sci B; 2014 Aug; 15(8):701-12. PubMed ID: 25091988
[TBL] [Abstract][Full Text] [Related]
26. Over-expression of PDGFR-β promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway.
Wang H; Yin Y; Li W; Zhao X; Yu Y; Zhu J; Qin Z; Wang Q; Wang K; Lu W; Liu J; Huang L
PLoS One; 2012; 7(2):e30503. PubMed ID: 22355314
[TBL] [Abstract][Full Text] [Related]
27. ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements.
Yu K; Zheng B; Han M; Wen JK
Cardiovasc Res; 2011 Jun; 90(3):464-74. PubMed ID: 21252119
[TBL] [Abstract][Full Text] [Related]
28. Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle.
Deaton RA; Gan Q; Owens GK
Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1027-37. PubMed ID: 19168719
[TBL] [Abstract][Full Text] [Related]
29. Triple-tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation.
Ambade AS; Jung B; Lee D; Doods H; Wu D
Transl Res; 2019 Jan; 203():15-30. PubMed ID: 30142307
[TBL] [Abstract][Full Text] [Related]
30. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
[TBL] [Abstract][Full Text] [Related]
31. Calpain-2 activates Akt via TGF-β1-mTORC2 pathway in pulmonary artery smooth muscle cells.
Abeyrathna P; Kovacs L; Han W; Su Y
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C24-34. PubMed ID: 27099352
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
Yokota T; Utsunomiya K; Taniguchi K; Gojo A; Kurata H; Tajima N
Jpn J Ophthalmol; 2007; 51(6):424-30. PubMed ID: 18158592
[TBL] [Abstract][Full Text] [Related]
33. Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.
Jasińska-Stroschein M; Owczarek J; Plichta P; Orszulak-Michalak D
Pharmacology; 2014; 93(3-4):145-50. PubMed ID: 24662671
[TBL] [Abstract][Full Text] [Related]
34. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
[TBL] [Abstract][Full Text] [Related]
35. Platelet-derived growth factor up-regulates Ca
Yamamura A; Nayeem MJ; Al Mamun A; Takahashi R; Hayashi H; Sato M
FASEB J; 2019 Jun; 33(6):7363-7374. PubMed ID: 30865840
[TBL] [Abstract][Full Text] [Related]
36. TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis.
Yang L; Peng Z; Gong F; Yan W; Shi Y; Li H; Zhou C; Yao H; Yuan M; Yu F; Feng L; Wan N; Liu G
Free Radic Biol Med; 2024 Jul; 219():141-152. PubMed ID: 38636714
[TBL] [Abstract][Full Text] [Related]
37. Endothelial HIFα/PDGF-B to smooth muscle Beclin1 signaling sustains pathological muscularization in pulmonary hypertension.
Saddouk FZ; Kuzemczak A; Saito J; Greif DM
JCI Insight; 2024 Apr; 9(10):. PubMed ID: 38652543
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-induced secretion of platelet-derived growth factor-BB by hepatocellular carcinoma cells increases activated hepatic stellate cell proliferation, migration and expression of vascular endothelial growth factor-A.
Lu Y; Lin N; Chen Z; Xu R
Mol Med Rep; 2015 Jan; 11(1):691-7. PubMed ID: 25333351
[TBL] [Abstract][Full Text] [Related]
39. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling.
Jankov RP; Kantores C; Belcastro R; Yi S; Ridsdale RA; Post M; Tanswell AK
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1162-70. PubMed ID: 15722379
[TBL] [Abstract][Full Text] [Related]
40. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
